Celebrex (celecoxib), the first COX-2 selective NSAID to hit the market

January 1999

You're going to hear a lot about Celebrex (celecoxib), the first COX-2 selective NSAID to hit the market.

It'll be co-promoted by Searle and Pfizer.

Celebrex is approved for osteo- and rheumatoid arthritis. It's as effective as other NSAIDs for joint pain and swelling.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote